• Healthcare Triangle posted a net loss of USD 6.2 million for quarter ended March 31, 2026, widening from USD 1.7 million a year earlier.
• Revenue more than doubled to USD 9.86 million, up 166% from the prior-year quarter.
• Gross margin expanded to 24% from 9%, while sales and marketing expense climbed to USD 1.78 million, up 377%.
• Cash and cash equivalents totaled USD 4.32 million at March 31, 2026; cash used in operating activities was USD 6.86 million.
• Company highlighted integration plans for Teyame, aiming to expand AI-driven healthcare capabilities and cross-selling across customer bases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-056096), on May 14, 2026, and is solely responsible for the information contained therein.